Smith & Nephew Inc.
1450 Brooks Road
245 articles with Smith & Nephew Inc.
Smith & Nephew meniscal knee repair technology delivers 0% re-operation rate and 100% meniscal healing at six months shows first ever study of horizontal cleavage tears
Smith & Nephew, the global medical technology business, today announces the results of the first ever prospective clinical trial to evaluate the effectiveness of repairing Horizontal Cleavage Tears, one of the most common meniscal tears affecting approximately one-third of patients with this injury.
Smith & Nephew Launches the CONQUEST FN™ Femoral Neck Fracture System, a Fresh Approach to Hip Preservation Versus Current Treatment Options
Irrespective of age and bone quality, femoral neck fractures pose a significant clinical challenge with complication rates reported to be as high as 69% 1 depending on fracture type, patient population and therapeutic intervention.
Smith & Nephew's OXINIUM™ Technology for Hips could save the US Health System an estimated $296 Million in 2020
Smith & Nephew presented new data at the International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting in New Orleans.
Smith & Nephew launches new FLOW 90™ Wand at ISAKOS joining its innovative collection of COBLATION™ technology and shoulder repair portfolios
Smith & Nephew, the global medical technology business, announces the U.S. launch of the WEREWOLF™ FLOW 90 Wand with FLOW~IQ™ Technology.
New NICE guidance recognises that Smith & Nephew’s PICO™ sNPWT provides better outcomes than standard dressings in patients at high risk of surgical site infections, at similar overall cost
Smith & Nephew, the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health and Care Excellence.
Medical technology company consolidates study management on the Medidata Rave® Clinical Cloud
Smith & Nephew POLAR3™ Total Hip Solution demonstrates best-in-class results from world's largest registry
The POLARSTEM/R3 combination demonstrated the highest survivorship of any stem/cup combination regardless of fixation method at seven years
Smith & Nephew announced positive clinical results concerning its JOURNEY™ II Bi-Cruciate Stabilized (BCS) knees.
UK’s NICE Publishes a Medtech Innovation Briefing on PICO™ for the Prophylactic Use in Surgically Closed Incisions to Reduce Surgical Site Complications
Smith & Nephew announces that the UK's National Institute for Health and Care Excellence (NICE) has issued a Medtech innovation briefing (MIB) on the use of PICO Single Use Negative Pressure Wound Therapy (sNPWT).
Smith & Nephew: RCT Demonstrates A 71% Reduction In The Onset Of Sacral Pressure Ulcers When Adding ALLEVYN◊ LIFE To Standard Preventative Protocol
Published in the International Wound Journal, the RCT charts the experience of 359 fragile hip fracture patients aged 65 or over.
The plan is an effort to ward off pressure to break up the firm by activist investor Elliott Advisors.
The results show a near 75% decrease in readmission rates for joint arthroplasties conducted under its Episode of Care Assurance Program.
Two factors have increased speculation that Smith & Nephew may be ready for a takeover.
MolecuLight Signs Exclusive Distribution Agreement With Global Wound Care Leader Smith & Nephew Inc.
Smith & Nephew Inc. Release: Study Results Demonstrate 74% Reduction In Surgical Site Infections With Use Of PICO Single Use Negative Pressure Wound Therapy System
Smith & Nephew Inc. Release: Collagenase SANTYL Ointment Advances Pressure Ulcers Through The Healing Process Faster, New Study Suggests
Smith & Nephew Inc. Invests In And Signs Agreement To Distribute Disruptive Leaf Healthcare Pressure Injury Technology
Smith & Nephew Inc. Release: New WHO Guidelines Recommend The Use Of NPWT To Help Reduce The Risk Of Surgical Site Infection